Nicardipine Hydrochloride Patent Expiration
Nicardipine Hydrochloride is Used for lowering acute elevations of blood pressure in human subjects. It was first introduced by Chiesi Usa Inc
Nicardipine Hydrochloride Patents
Given below is the list of patents protecting Nicardipine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cardene In 0.83% Sodium Chloride In Plastic Container | US7612102 | Pre-mixed, ready-to-use pharmaceutical compositions | Dec 26, 2027 | Chiesi |
| Cardene In 0.83% Sodium Chloride In Plastic Container | US9364564 | Pre-mixed, ready-to-use pharmaceutical compositions | Dec 26, 2027 | Chiesi |
| Cardene In 0.86% Sodium Chloride In Plastic Container | US7612102 | Pre-mixed, ready-to-use pharmaceutical compositions | Dec 26, 2027 | Chiesi |
| Cardene In 0.86% Sodium Chloride In Plastic Container | US9364564 | Pre-mixed, ready-to-use pharmaceutical compositions | Dec 26, 2027 | Chiesi |
| Cardene In 4.8% Dextrose In Plastic Container | US7612102 | Pre-mixed, ready-to-use pharmaceutical compositions | Dec 26, 2027 | Chiesi |
| Cardene In 4.8% Dextrose In Plastic Container | US9364564 | Pre-mixed, ready-to-use pharmaceutical compositions | Dec 26, 2027 | Chiesi |
| Cardene In 5.0% Dextrose In Plastic Container | US7612102 | Pre-mixed, ready-to-use pharmaceutical compositions | Dec 26, 2027 | Chiesi |
| Cardene In 5.0% Dextrose In Plastic Container | US9364564 | Pre-mixed, ready-to-use pharmaceutical compositions | Dec 26, 2027 | Chiesi |
| Cardene In 0.83% Sodium Chloride In Plastic Container | US10758616 | Pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 0.83% Sodium Chloride In Plastic Container | US11547758 | Pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 0.83% Sodium Chloride In Plastic Container | US7659291 | Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 0.83% Sodium Chloride In Plastic Container | US8455524 | Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 0.86% Sodium Chloride In Plastic Container | US10758616 | Pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 0.86% Sodium Chloride In Plastic Container | US11547758 | Pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 0.86% Sodium Chloride In Plastic Container | US7659291 | Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 0.86% Sodium Chloride In Plastic Container | US8455524 | Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 4.8% Dextrose In Plastic Container | US10758616 | Pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 4.8% Dextrose In Plastic Container | US11547758 | Pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 4.8% Dextrose In Plastic Container | US7659291 | Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 4.8% Dextrose In Plastic Container | US8455524 | Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 5.0% Dextrose In Plastic Container | US7659291 | Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
| Cardene In 5.0% Dextrose In Plastic Container | US8455524 | Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Apr 18, 2027 | Chiesi |
Nicardipine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Nicardipine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Nicardipine Hydrochloride. The first generic version for Nicardipine Hydrochloride was by Norvium Bioscience Llc and was approved on Jul 18, 1996. And the latest generic version is by Amneal Eu Ltd and was approved on Oct 31, 2024.
Given below is the list of companies who have filed for Nicardipine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. AM REGENT
American Regent Inc has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Am Regent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG/10ML (2.5MG/ML)
(reference standard) | injectable | Prescription | INJECTION | AP | Nov 17, 2009 |
2. AMNEAL
Amneal Eu Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG/10ML (2.5MG/ML) | injectable | Prescription | INJECTION | AP | Oct 31, 2024 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
3. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | capsule | Discontinued | ORAL | N/A | Dec 10, 1996 |
| 30MG | capsule | Discontinued | ORAL | N/A | Dec 10, 1996 |
4. BIONPHARMA
Bionpharma Inc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule | Prescription | ORAL | AB | May 3, 2023 |
| 20MG | capsule | Prescription | ORAL | AB | May 3, 2023 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
5. CHENGDU SHUODE
Chengdu Shuode Pharmaceutical Co Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Chengdu Shuode.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG/10ML (2.5MG/ML) | injectable | Prescription | INJECTION | AP | Sep 6, 2024 |
6. CIPLA
Cipla Ltd has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. All of these versions come by the name NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/200ML (0.1MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Sep 24, 2024 |
| 40MG/200ML (0.2MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Sep 24, 2024 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
7. EPIC PHARMA LLC
Epic Pharma Llc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG
(reference standard) | capsule | Prescription | ORAL | AB | Mar 19, 1998 |
| 20MG | capsule | Prescription | ORAL | AB | Mar 19, 1998 |
8. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG/10ML (2.5MG/ML) | injectable | Prescription | INJECTION | AP | Apr 8, 2021 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
9. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule | Prescription | ORAL | AB | Dec 16, 2022 |
| 20MG | capsule | Prescription | ORAL | AB | Dec 16, 2022 |
10. INFORLIFE
Inforlife Sa has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Out of these 20mg/200ml (0.1mg/ml) version comes by the name NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE, 40mg/200ml (0.2mg/ml) version comes by the name NICARDIPINE HYDROCHLORIDE IN 0.83% SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Inforlife.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/200ML (0.1MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Apr 17, 2024 |
| 40MG/200ML (0.2MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Apr 17, 2024 |
Manufacturing Plant Locations New
Inforlife's manufacturing plants are situated in 1 country - Switzerland. Given below are the details of these plant locations as well as the firm names of Inforlife as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| Switzerland |
| |||
11. MICRO LABS
Micro Labs Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG/10ML (2.5MG/ML) | injectable | Prescription | INJECTION | AP | Jul 7, 2023 |
Manufacturing Plant Locations New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
12. NAVINTA LLC
Navinta Llc has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Navinta Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG/10ML (2.5MG/ML) | injectable | Discontinued | INJECTION | N/A | Nov 17, 2009 |
13. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | capsule | Discontinued | ORAL | N/A | Jul 18, 1996 |
| 30MG | capsule | Discontinued | ORAL | N/A | Jul 18, 1996 |
14. RK PHARMA
Rk Pharma Inc has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rk Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG/10ML (2.5MG/ML) | injectable | Prescription | INJECTION | AP | Nov 17, 2009 |
Manufacturing Plant Locations New
Rk Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Rk Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
15. SENORES PHARMS
Senores Pharmaceuticals Inc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Senores Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule | Prescription | ORAL | AB | Jul 17, 2023 |
| 20MG | capsule | Prescription | ORAL | AB | Jul 17, 2023 |
16. SKG PHARMA
Skg Pharma Inc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Skg Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule | Prescription | ORAL | AB | Apr 10, 2024 |
| 20MG | capsule | Prescription | ORAL | AB | Apr 10, 2024 |
17. WEST-WARD PHARMS INT
West-ward Pharmaceuticals International Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG/10ML (2.5MG/ML) | injectable | Discontinued | INJECTION | N/A | Dec 28, 2009 |
18. WOCKHARDT
Wockhardt Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wockhardt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG/10ML (2.5MG/ML) | injectable | Prescription | INJECTION | AP | Nov 17, 2009 |
Manufacturing Plant Locations New
Wockhardt's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Wockhardt as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||